Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: SRI INTERNATIONAL
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-06-02 to 2027-06-01
Current total value of award: $1249426.22
Description: NICHD: R&D: ESSENTIAL STUDIES AND MANUFACTURE FOR CURRENT PRODUCTS IN ONGOING CLINICAL DEVELOPMENT: NON-SEVERABLE